C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/40 (2006.01) A61K 39/12 (2006.01) C07K 14/08 (2006.01) C07K 14/18 (2006.01) C12N 7/00 (2006.01) C12N 7/01 (2006.01) C12N 7/04 (2006.01) C12N 15/86 (2006.01) A61K 38/00 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2336554
Using the MBGV GP, NP and virion proteins, a method and composition for use in inducing an immune response which is protective against infection with MBGV in nonhuman primates is described.
L'invention concerne l'utilisation du virus de Marburg (MBGV), d'une glycoprotéine de surface (GP), d'une nucléoprotéine (NP) et d'autres protéines de la particule virale; elle concerne également un procédé et une composition utiles pour induire une réponse immune, protégeant des primats non humains de l'infection par MBGV.
Hevey Michael C.
Negley Diane L.
Pushko Peter
Schmaljohn Alan L.
Smith Jonathan F.
Johnson Ernest Peter
U.s. Medical Research Institute Of Infectious Diseases
LandOfFree
Marburg virus vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Marburg virus vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Marburg virus vaccines will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2032866